See details of a Senate Inquiry into: The availability of new, innovative and specialist cancer drugs in Australia.
The terms of reference are:
- the timing and affordability of access for patients;
- the operation of the Pharmaceutical Benefits Advisory Committee and the Pharmaceutical Benefits Scheme in relation to such drugs, including the impact of delays in the approvals process for Australian patients;
- the impact on the quality of care available to cancer patients; and
- any related matters.
See the Report at http://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs/Cancer_Drugs
Submissions by Cancer Voices SA and Cancer Voices Australia. Senate website for all submissions.
